Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force.
Bipolar Disord. 2024 May;26(3):216-239. doi: 10.1111/bdi.13414. Epub 2024 Mar 3.
Bipolar Disord. 2024.
PMID: 38433530
Review.
Bipolar-ADHD comorbidity: screening for differences in neurocognition and virtual reality-based cognitive performance.
Jespersen AE, Obel Z, Lumbye A, Kessing LV, Miskowiak KW.
Jespersen AE, et al.
Nord J Psychiatry. 2024 Apr;78(3):238-246. doi: 10.1080/08039488.2024.2309496. Epub 2024 Jan 31.
Nord J Psychiatry. 2024.
PMID: 38294688
Item in Clipboard
Implementing cognitive screenings for outpatients with bipolar disorder following optimised treatment in a specialised mood disorder clinic.
Miskowiak KW, Roikjer TK, Mariegaard J, Bech JL, Obel ZK, Vejstrup B, Hansen L, Kessing LV.
Miskowiak KW, et al. Among authors: obel zk.
Eur Neuropsychopharmacol. 2024 Apr 20;84:27-34. doi: 10.1016/j.euroneuro.2024.04.013. Online ahead of print.
Eur Neuropsychopharmacol. 2024.
PMID: 38643698
Free article.
Item in Clipboard
Cite
Cite